Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Day

Showing results (91-100 of 121) with videos related to

Pageof 13
Sort By:
Hepatology (Baltimore, Md.)|April 8, 2010
Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver diseaseLuca Valenti, Ahmad Al-Serri, Ann K Daly, et al.
Plos One|April 19, 2017
A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitisStuart McPherson, Nina Wilkinson, Dina Tiniakos, et al.
Alcoholism, Clinical and Experimental Research|May 1, 2008
No role of matrixmetalloproteinase-3 genetic promoter polymorphism 1171 as a risk factor for cirrhosis in alcoholic liver diseaseFelix Stickel, Christoph H Osterreicher, Juliane Halangk, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 18, 2014
Lack of efficacy of an inhibitor of PDE4 in phase 1 and 2 trials of patients with nonalcoholic steatohepatitisVlad Ratziu, Pierre Bedossa, Sven M Francque, et al.
The American Journal of Gastroenterology|October 12, 2016
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD FibrosisStuart McPherson, Tim Hardy, Jean-Francois Dufour, et al.
The American Journal of Gastroenterology|July 7, 2015
Corrigendum: PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver DiseaseHabeeb Salameh, Evan Raff, Angelika Erwin, et al.
The Journal of Clinical Investigation|January 7, 2015
Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosisChris J Weston, Emma L Shepherd, Lee C Claridge, et al.
Hepatology (Baltimore, Md.)|March 30, 2007
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLDPaul Angulo, Jason M Hui, Giulio Marchesini, et al.
Journal of Inflammation (London, England)|April 1, 2010
Elevated endotoxin levels in non-alcoholic fatty liver diseaseAlison L Harte, Nancy F da Silva, Steven J Creely, et al.
Journal of Hepatology|February 16, 2019
The degree of hepatic steatosis associates with impaired cardiac and autonomic functionDavid Houghton, Paweł Zalewski, Kate Hallsworth, et al.
Pageof 13

Showing results (91-100 of 121) with videos related to

Sort By:
Pageof 13
Hepatology (Baltimore, Md.)|April 8, 2010
Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver diseaseLuca Valenti, Ahmad Al-Serri, Ann K Daly, et al.
Plos One|April 19, 2017
A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitisStuart McPherson, Nina Wilkinson, Dina Tiniakos, et al.
Alcoholism, Clinical and Experimental Research|May 1, 2008
No role of matrixmetalloproteinase-3 genetic promoter polymorphism 1171 as a risk factor for cirrhosis in alcoholic liver diseaseFelix Stickel, Christoph H Osterreicher, Juliane Halangk, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 18, 2014
Lack of efficacy of an inhibitor of PDE4 in phase 1 and 2 trials of patients with nonalcoholic steatohepatitisVlad Ratziu, Pierre Bedossa, Sven M Francque, et al.
The American Journal of Gastroenterology|October 12, 2016
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD FibrosisStuart McPherson, Tim Hardy, Jean-Francois Dufour, et al.
The American Journal of Gastroenterology|July 7, 2015
Corrigendum: PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver DiseaseHabeeb Salameh, Evan Raff, Angelika Erwin, et al.
The Journal of Clinical Investigation|January 7, 2015
Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosisChris J Weston, Emma L Shepherd, Lee C Claridge, et al.
Hepatology (Baltimore, Md.)|March 30, 2007
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLDPaul Angulo, Jason M Hui, Giulio Marchesini, et al.
Journal of Inflammation (London, England)|April 1, 2010
Elevated endotoxin levels in non-alcoholic fatty liver diseaseAlison L Harte, Nancy F da Silva, Steven J Creely, et al.
Journal of Hepatology|February 16, 2019
The degree of hepatic steatosis associates with impaired cardiac and autonomic functionDavid Houghton, Paweł Zalewski, Kate Hallsworth, et al.
Pageof 13